{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T01:52:17Z","timestamp":1785894737609,"version":"3.56.0"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:00:00Z","timestamp":1780876800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100013123","name":"ResearchNB","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013123","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000143","name":"Alzheimer Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000143","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008914","name":"Ontario Brain Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008914","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000106","name":"Saskatchewan Health Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000106","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009408","name":"Fondation Brain Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009408","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005266","name":"Women&apos;s Health Initiative","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005266","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["FRN1632902"],"award-info":[{"award-number":["FRN1632902"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jns.2026.126047","type":"journal-article","created":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T23:23:45Z","timestamp":1780961025000},"page":"126047","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Application of a clinical scale for predicting A\u03b2-positivity in a multicentre Canadian dementia cohort: A necessity in the era of amyloid targeting treatment"],"prefix":"10.1016","volume":"488","author":[{"given":"Durjoy","family":"Lahiri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaaminy","family":"Kathir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoya","family":"Punjwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stamatoula","family":"Pasvanis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruna","family":"Seixas-Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Tyler","family":"Roncero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard","family":"Chertkow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jns.2026.126047_bb0005","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcab008","article-title":"Detection of \u03b2-amyloid positivity in Alzheimer\u2019s disease neuroimaging initiative participants with demographics, cognition, MRI and plasma biomarkers","volume":"3","author":"Tosun","year":"2021","journal-title":"Brain Communications"},{"issue":"12","key":"10.1016\/j.jns.2026.126047_bb0010","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1001\/jamaneurol.2024.3770","article-title":"Alzheimer disease as a clinical-biological construct\u2014an international working group recommendation","volume":"81","author":"Dubois","year":"2024","journal-title":"JAMA Neurol."},{"issue":"3","key":"10.1016\/j.jns.2026.126047_bb0015","doi-asserted-by":"crossref","DOI":"10.1002\/alz.14528","article-title":"Considerations in the clinical use of amyloid PET and CSF biomarkers for Alzheimer\u2019s disease","volume":"21","author":"Leuzy","year":"2025","journal-title":"Alzheimers Dement."},{"issue":"1","key":"10.1016\/j.jns.2026.126047_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e41445","article-title":"Exploring peripheral fluid biomarkers for early detection of Alzheimer\u2019s disease in down syndrome: a literature review","volume":"11","author":"Jacob","year":"2025","journal-title":"Heliyon"},{"key":"10.1016\/j.jns.2026.126047_bb0025","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.cca.2021.05.011","article-title":"The PrecivityAD\u2122 test: accurate and reliable LC-MS\/MS assays for quantifying plasma amyloid beta 40 and 42 and apolipoprotein E proteotype for the assessment of brain amyloidosis","volume":"519","author":"Kirmess","year":"2021","journal-title":"Clin. Chim. Acta"},{"issue":"11","key":"10.1016\/j.jns.2026.126047_bb0030","article-title":"Blood-based Alzheimer\u2019s disease biomarkers in a behavioral neurology clinic: real-world implementation, clinical utility, and diagnostic performance","volume":"21","author":"Prufer","year":"2025","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.jns.2026.126047_bb0035","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2024.1422681","article-title":"CAPS: a simple clinical tool for \u03b2-amyloid positivity prediction in clinical Alzheimer syndrome","volume":"15","author":"Lahiri","year":"2024","journal-title":"Front. Neurol."},{"issue":"4","key":"10.1016\/j.jns.2026.126047_bb0040","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.3233\/JAD-221030","article-title":"Biomarkers and risk assessment of Alzheimer\u2019s disease in low- and middle-income countries","volume":"95","author":"Adewale","year":"2023","journal-title":"JAD"},{"issue":"1","key":"10.1016\/j.jns.2026.126047_bb0045","article-title":"Alzheimer\u2019s disease diagnosis and management: perspectives from around the world","volume":"14","author":"Kerwin","year":"2022","journal-title":"Alzheimers Dement. Diagn. Assess. Dis. Monit."},{"key":"10.1016\/j.jns.2026.126047_bb0050","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2023.1198869","article-title":"A task force for diagnosis and treatment of people with Alzheimer\u2019s disease in Latin America","volume":"14","author":"Lopera","year":"2023","journal-title":"Front. Neurol."},{"issue":"5","key":"10.1016\/j.jns.2026.126047_bb0055","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1017\/cjn.2019.27","article-title":"The comprehensive assessment of neurodegeneration and dementia: Canadian cohort study","volume":"46","author":"Chertkow","year":"2019","journal-title":"Can. J. Neurol. Sci."},{"issue":"2","key":"10.1016\/j.jns.2026.126047_bb0060","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1002\/jmri.26197","article-title":"The Canadian dementia imaging protocol: harmonizing National Cohorts","volume":"49","author":"Duchesne","year":"2019","journal-title":"Magn. Reson. Imaging"},{"key":"10.1016\/j.jns.2026.126047_bb0065","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3389\/fninf.2018.00085","article-title":"National neuroinformatics framework for Canadian Consortium on Neurodegeneration in Aging (CCNA)","volume":"12","author":"Mohaddes","year":"2018","journal-title":"Front. Neuroinform."},{"issue":"3","key":"10.1016\/j.jns.2026.126047_bb0070","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1111\/jgs.18124","article-title":"Conversion between the Montreal cognitive assessment and the Mini-Mental status examination","volume":"71","author":"Fasnacht","year":"2023","journal-title":"J. Am. Geriatr. Soc."},{"issue":"S14","key":"10.1016\/j.jns.2026.126047_bb0075","doi-asserted-by":"crossref","DOI":"10.1002\/alz.075037","article-title":"A comparative study of Amyloid positive and negative individuals with \u201cAlzheimer Syndrome\u201d","volume":"19","author":"Lahiri","year":"2023","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.jns.2026.126047_bb0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/cjn.2026.10530","article-title":"CAPS plus: a clinical biomarker scoring system to predict a\u03b2 positivity and facilitate enrolment in anti-amyloid clinical trials","author":"Lahiri","year":"2026","journal-title":"Can. J. Neurol. Sci."},{"issue":"10","key":"10.1016\/j.jns.2026.126047_bb0085","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1002\/(SICI)1099-1166(199710)12:10<1008::AID-GPS676>3.0.CO;2-A","article-title":"Age- and education-specific reference values for the Mini-mental and modified Mini-mental state examinations derived from a non-demented elderly population","volume":"12","author":"Bravo","year":"1997","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.jns.2026.126047_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2021.101459","article-title":"Female specific risk factors for the development of Alzheimer\u2019s disease neuropathology and cognitive impairment: call for a precision medicine approach","volume":"71","author":"Udeh-Momoh","year":"2021","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.jns.2026.126047_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinbiochem.2023.110680","article-title":"Age specific reference intervals for plasma biomarkers of neurodegeneration and neurotrauma in a Canadian population","volume":"121-122","author":"Cooper","year":"2023","journal-title":"Clin. Biochem."},{"issue":"7","key":"10.1016\/j.jns.2026.126047_bb0100","doi-asserted-by":"crossref","DOI":"10.1002\/gps.5960","article-title":"Relationships between neuropsychiatric symptoms and cognitive profiles in Alzheimer\u2019s disease and related syndromes","volume":"38","author":"Seixas-Lima","year":"2023","journal-title":"Int. J. Geriatr. Psychiatry"},{"issue":"1","key":"10.1016\/j.jns.2026.126047_bb0105","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s13195-022-00991-z","article-title":"Sex differences in neuropsychiatric symptoms in Alzheimer\u2019s disease dementia: a meta-analysis","volume":"14","author":"Eikelboom","year":"2022","journal-title":"Alz. Res. Ther."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X26003291?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X26003291?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T01:32:19Z","timestamp":1785893539000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X26003291"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":21,"alternative-id":["S0022510X26003291"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2026.126047","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Application of a clinical scale for predicting A\u03b2-positivity in a multicentre Canadian dementia cohort: A necessity in the era of amyloid targeting treatment","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2026.126047","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"126047"}}